470 related articles for article (PubMed ID: 11930292)
41. Osteoporosis: strategies for prevention and management.
Keen R
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
[TBL] [Abstract][Full Text] [Related]
42. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
[No Abstract] [Full Text] [Related]
43. Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis.
Woo T; Adachi JD
Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):469-81. PubMed ID: 11485341
[TBL] [Abstract][Full Text] [Related]
44. The osteoporosis care gap in Canada.
Papaioannou A; Giangregorio L; Kvern B; Boulos P; Ioannidis G; Adachi JD
BMC Musculoskelet Disord; 2004 Apr; 5():11. PubMed ID: 15068488
[TBL] [Abstract][Full Text] [Related]
45. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
[TBL] [Abstract][Full Text] [Related]
46. [Diagnosis and pharmacologic therapy of osteoporosis].
Lakatos P
Orv Hetil; 2003 Jul; 144(28):1373-9. PubMed ID: 12914121
[TBL] [Abstract][Full Text] [Related]
47. [Progress in the treatment of osteoporosis].
Sugimoto T
Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
[TBL] [Abstract][Full Text] [Related]
48. [Osteoporosis treatment--state of the art].
Sørensen OH; Jensen JE
Nord Med; 1993; 108(11):289-92. PubMed ID: 8247719
[TBL] [Abstract][Full Text] [Related]
49. [Up-to-date treatments for osteoporosis].
Bors K
Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
[TBL] [Abstract][Full Text] [Related]
50. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
51. Present and future of osteoporosis therapy.
Seeman E; Tsalamandris C; Bass S; Pearce G
Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
[TBL] [Abstract][Full Text] [Related]
52. Treatment of osteoporosis: where are we and where are we going to.
Reginster JY
Morphologie; 1999 Jun; 83(261):41-5. PubMed ID: 10546235
[TBL] [Abstract][Full Text] [Related]
53. [Bone diseases with Pain. Osteoporosis].
Hayashi Y
Clin Calcium; 2007 Apr; 17(4):606-12. PubMed ID: 17404492
[TBL] [Abstract][Full Text] [Related]
54. Drug insight: Existing and emerging therapies for osteoporosis.
Mulder JE; Kolatkar NS; LeBoff MS
Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
56. Fracture prevention in postmenopausal women.
Mosekilde L; Vestergaard P; Langdahl B
Clin Evid; 2006 Jun; (15):1543-60. PubMed ID: 16973058
[No Abstract] [Full Text] [Related]
57. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
Azuma K
Clin Calcium; 2009 Sep; 19(9):1345-52. PubMed ID: 19721208
[TBL] [Abstract][Full Text] [Related]
58. New approaches to pharmacological treatment of osteoporosis.
Akesson K
Bull World Health Organ; 2003; 81(9):657-64. PubMed ID: 14710507
[TBL] [Abstract][Full Text] [Related]
59. Osteoporosis: part II. Nonpharmacologic and pharmacologic treatment.
South-Paul JE
Am Fam Physician; 2001 Mar; 63(6):1121-8. PubMed ID: 11277549
[TBL] [Abstract][Full Text] [Related]
60. [Osteoporosis therapy, current status].
Felder M; Dambacher MA
Schweiz Rundsch Med Prax; 1994 Jan; 83(3):84-6. PubMed ID: 8296136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
